These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6132927)

  • 1. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
    Pipeleers D; Somers G; Gepts W; De Nutte N; De Vroede M
    J Clin Endocrinol Metab; 1979 Oct; 49(4):572-9. PubMed ID: 158032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic polypeptide in somatostatinoma.
    Pinsard D; Odent S; Chadenas D
    Dig Dis Sci; 1986 Apr; 31(4):445-6. PubMed ID: 2869926
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant somatostatinoma: clinical features and metabolic studies.
    Axelrod L; Bush MA; Hirsch HJ; Loo SW
    J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative diagnostic value of the calcium-pentagastrin test versus the tolbutamide test in a patient with a somatostatinoma.
    Budmiger H; Bühler H; Häcki W; Stamm B; Streuli R; Ammann R
    Gastroenterology; 1987 Mar; 92(3):800-4. PubMed ID: 3028898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of duodenal somatostatinoma: diagnostic usefulness of calcium--pentagastrin test.
    Somers G; Pipeleers-Marichal M; Gepts W; Pipeleers D
    Gastroenterology; 1983 Nov; 85(5):1192-8. PubMed ID: 6137434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
    Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of sodium valproate on plasma somatostatin and insulin in humans.
    Kusunoki M; Yamamura T; Ichii S; Fujita S; Nakai T; Utsunomiya J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1060-3. PubMed ID: 2903170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatinoma syndrome: does a clinical entity exist?
    Stacpoole PW; Kasselberg AG; Berelowitz M; Chey WY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):80-7. PubMed ID: 6297217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic somatostatinoma: presentation with recurrent episodes of severe hyperglycaemia and ketoacidosis.
    Willcox PA; Immelman EJ; Barron JL; Klaff LJ; Harries-Jones EP; Hainsworth M; Millar RP
    Q J Med; 1988 Jul; 68(255):559-71. PubMed ID: 2855274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Somatostatinoma of the pancreas].
    Machado MC; Alves VA; Wakamatsu A; Bacchella T; Cunha JE; Pupo AA; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):222-6. PubMed ID: 2899904
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
    Rehfeld JF
    Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatinoma syndrome accompanied by overproduction of pancreatic polypeptide.
    Nakanome C; Koizumi M; Fujiya H; Akai H; Toyota T; Goto Y; Kameyama J; Miyakawa K; Hanew K
    Tohoku J Exp Med; 1984 Feb; 142(2):201-10. PubMed ID: 6144197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
    Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
    Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the diagnosis of somatostatinoma.
    Somers G; Gepts W; Pipeleers D
    Acta Gastroenterol Belg; 1982; 45(7-8):322-6. PubMed ID: 6301190
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose turnover and gluconeogenesis in a patient with somatostatinoma.
    Lowry SF; Burt ME; Brennan MF
    Surgery; 1981 Mar; 89(3):309-13. PubMed ID: 6110246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.